| View |
|
DRP-14739-01
|
Quetiapine (as fumarate)
|
Quetigrand 100
|
100 mg
|
Film-Coated Tablet
|
Antipsychotic
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 March 2024
|
20 December 2028
|
| View |
|
DRP-14777-01
|
Norepinephrine (as bitartrate)
|
Epinorine 1
|
1 mg/mL (4 mg/4 mL)
|
Solution for Injection (I.V. Infusion)
|
Adrenergic/ Dopaminergic Agent
|
Ultra Laboratories Private Limited
|
India
|
CLIDP Conversion
|
25 March 2024
|
03 January 2029
|
| View |
|
DRP-14855-01
|
Polyethylene Glycol + Glycerin + Hypromellose
|
ICARE
|
10 mg/2 mg/2 mg per mL
|
Ophthalmic Solution (Eye Drops)
|
Ophthalmic Lubricant
|
Hanlim Pharmaceutical Co., Ltd.
|
Korea
|
CLIDP Conversion
|
24 March 2024
|
01 February 2029
|
| View |
|
DRP-14858-01
|
Paracetamol
|
Parazamil
|
10 mg/mL
|
Solution for Injection (IV)
|
Analgesic/Antipyretic
|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
24 March 2024
|
22 December 2028
|
| View |
|
DRP-1617-05
|
Ampicillin (as sodium)
|
Amzellin-500
|
500 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Penicillin with extended spectrum)
|
Inject Care Parenterals Pvt. Ltd
|
India
|
Renewal
|
25 July 2024
|
03 September 2029
|
| View |
|
DRP-1646-11
|
Salbutamol (as sulfate) + Guaifenesin
|
Asvent Plus
|
1 mg/ 50 mg per 5 mL
|
Syrup
|
Beta-2-Adrenoreceptor Agonist/Expectorant
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
17 March 2024
|
12 March 2026
|
| View |
|
DRP-1651-07
|
FOLIC ACID
|
Zeofol
|
5 mg
|
Tablet
|
Vitamin/Hematinic
|
LifeSquare Laboratories Inc.
|
Philippines
|
Renewal
|
19 May 2024
|
25 September 2029
|
| View |
|
DRP-1721-03
|
Atorvastatin
|
Gostat 10
|
10 mg
|
Film-Coated Tablet
|
Antihyperlipidemic
|
Umedica Laboratories Pvt. Ltd.
|
India
|
Renewal
|
31 May 2024
|
25 August 2029
|
| View |
|
DRP-1739-05
|
dI-Alpha Tocopheryl Acetate (Vitamin E)
|
Evirose-400
|
400 I.U.
|
Softgel Capsule
|
Vitamin
|
XL Laboratories Pvt. Ltd.
|
India
|
Initial [CLIDP]
|
18 June 2021
|
23 November 2024
|
| View |
|
DRP-2223-05
|
Ampicillin (as sodium)
|
Amzellin-250
|
250 mg / vial
|
Powder for Injection (IV/IM)
|
Antibacterial (Penicillin)
|
Inject Care Parenterals Pvt. Ltd
|
India
|
CLIDP Conversion
|
28 March 2024
|
03 June 2025
|
| View |
|
DRP-236-14
|
Multivitamins + Iron
|
Iroferron
|
(see reverse for formulation)
|
Capsule
|
Hematinic
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
17 March 2024
|
19 November 2025
|
| View |
|
DRP-13801-01
|
Sugammadex (as sodium)
|
Reverse
|
100 mg/mL
|
Solution for Injection (IV)
|
Antidote
|
Aspiro Pharma Limited
|
India
|
CLIDP Conversion
|
31 July 2023
|
27 April 2028
|
| View |
|
DRP-3010-02
|
Enalapril Maleate
|
Normbeat 5
|
5 mg
|
Tablet
|
Angiotensin Converting Enzyme (ACE) Inhibitor
|
XL Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
25 March 2024
|
10 December 2029
|
| View |
|
DRP-3123-05
|
Atorvastatin (as Calcium)
|
Atorschwartz 10
|
10 mg
|
Film-Coated Tablet
|
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
29 March 2024
|
12 July 2029
|
| View |
|
DRP-3126-07
|
Clopidogrel (as bisulfate)
|
None
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic
|
Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)
|
India
|
CLIDP Conversion
|
21 March 2024
|
14 July 2029
|
| View |
|
DRP-316-04
|
Amoxicillin (as Trihydrate)
|
Limoxil
|
500 mg
|
Capsule
|
Antibacterial (Penicillin)
|
Flamingo Pharmaceuticals Ltd
|
India
|
Automatic Renewal
|
19 March 2024
|
10 March 2029
|
| View |
|
DRP-3168-01
|
Clopidogrel Bisulfate
|
Plogrel
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic
|
Ajanta Pharma Limited
|
India
|
Automatic Renewal
|
27 March 2024
|
16 July 2029
|
| View |
|
DRP-3205-01
|
Co-Amoxiclav
|
Orapen Inj
|
1 g/ 200 mg
|
Powder for Injection (I.V.)
|
Antibacterial (Penicillin-Beta-Lactamase Inhibitor Combination)
|
Inject Care Parenterals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
29 March 2024
|
23 August 2026
|
| View |
|
DRP-3322-06
|
Azithromycin (as Dihydrate)
|
Altozith
|
200 mg/5 mL
|
Powder for Suspension
|
Antibacterial (Macrolide)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
25 March 2024
|
08 July 2029
|
| View |
|
DRP-3322-07
|
Azithromycin (as Dihydrate)
|
Phartobac
|
200 mg/5 mL
|
Powder for Suspension
|
Antibacterial (Macrolide)
|
Stallion Laboratories Pvt. Ltd
|
India
|
Automatic Renewal
|
26 March 2024
|
08 July 2029
|